We observed an association between greater percentage increases in IGF1 levels -calculated as the increase in IGF1 levels between weeks 3 and 5 of life in relation to the levels existing in the 3rd week- and the risk of developing proliferative ROP [28.97%, CI 95% (−1.18–59.13)]. This evidence concerns the gene IGF1 and retinopathy of prematurity.